Cresco Labs closes US$50 million revolving credit facility
The facility from Needham Bank provides non-dilutive capital for growth and acquisitions at a 7.99% fixed rate maturing in 2030.
See the latest news and media coverage for Cresco Labs. We track all announcements, press releases, and industry mentions in real time, all in one place.
Cannabis producer and retailer
crescolabs.comLast updated
In short: Cresco Labs achieved significant operational growth through facility expansions, strategic refinancing, and federal regulatory milestones.
The facility from Needham Bank provides non-dilutive capital for growth and acquisitions at a 7.99% fixed rate maturing in 2030.
This follows federal rescheduling of cannabis to Schedule III, marking federal recognition of its operations.
The company maintains its application merits a license and is evaluating options to protect the original determination.
Revenue reaches $151 million with Adjusted EBITDA of $33 million. Advances growth with Texas license and new Ohio dispensaries.
CRLBF is down 28.5% YTD as revenue pressure and competition persist, but retail expansion and improving estimates could shape its next move.
Cresco Labs OTC () has held its Q1 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks. Unlock trusted...
Access to commercial bank financing enhances financial flexibility and supports Cresco Labs' disciplined growth and consolidation strategy.
The Brief A federal class-action lawsuit accuses three Chicago-based cannabis companies of...
Track Cresco Labs and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.